The FDA sent out “100 cease-and-desist letters” to brands in response to what it says is “deceptive” pharma advertising – which could massively impact pharma’s $7 billion U.S. national TV ad
marketplace.
The FDA sent out “100 cease-and-desist letters” to brands in response to what it says is “deceptive” pharma advertising – which could massively impact pharma’s $7 billion U.S. national TV ad
marketplace.